Interactions of oxidative stress with thiamine homeostasis promote neurodegeneration

Neurochemistry International

Volumn 40, Issue 6, 2002, Pages 493-504

  Gibson, Gary E ^a   Zhang, Hui ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Ketoglutarate dehydrogenase complex; Alzheimer's disease; Oxidative stress; Parkinson's disease; Pyruvate dehydrogenase complex; Thiamine

Indexed keywords

ANTIOXIDANT; THIAMINE;

ANTIOXIDANT ACTIVITY; ARTICLE; HOMEOSTASIS; HUMAN; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; THIAMINE DEFICIENCY;

ANIMALS; BRAIN CHEMISTRY; HOMEOSTASIS; HUMANS; NERVE DEGENERATION; OXIDATIVE STRESS; PHOSPHATES; THIAMINE;

EID: 0036176566     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(01)00120-6     Document Type: Article

References (101)

1. Frontal lobe dysfunction in progressive supranuclear palsy: Evidence for oxidative stress and mitochondrial impairment
2. Identification of the essential cysteine residue in the active site of bovine pyruvate dehydrogenase
3. The nonmetabolic role of thiamine in excitable membrane function
4. Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?
5. Thiamine in excitable tissues: Reflections on a non-cofactor role
6. Low thiamine diphosphate levels in brains of patients with frontal lobe degeneration of the non-Alzheimer's type
7. Inborn errors of pyruvate metabolism
8. Abnormality of a thiamine-requiring enzyme in patients with Wernicke-Korsakoff Syndrome
9. The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease
10. Thiamine and Alzheimer's disease: A pilot study
11. Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: Comparison with aminoguanidine
12. In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways
13. Thiamine and folate treatment of chronic epileptic patients: A controlled study with the Wechsler IQ scale
14. Regulation of alpha-ketoglutarate dehydrogenase cooperative properties in substrate binding by thiol-disulfide exchange
15. Thiamine-dependent enzyme changes in temporal cortex of patients with Alzheimer's disease
16. Dietary restriction attenuates the neuronal loss, induction of heme oxygenase-1 and blood-brain barrier breakdown induced by impaired oxidative metabolism
17. Vascular factors are critical in selective neuronal loss in an animal model of impaired oxidative metabolism
18. Parkinson disease: A new link between monoamine oxidase and mitochondrial electron flow
19. Pathogenesis of inclusion bodies in (CAG)n/Qn-expansion diseases with special reference to the role of tissue transglutaminase and to selective vulnerability
20. A treatment for tardive dyskinesia and some other extrapyramidal symptoms
21. Glucose and memory in mild senile dementia of the Alzheimer type
22. Electron histochemical evidence for the role of thiamine pyrophosphatase in synaptic transmission
23. Neurofibrillary tangles in chronic alcoholics
24. The role of thiamine in maple syrup urine disease
25. Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative
26. Inhibition of acetylcholine synthesis and of carbohydrate utilization by maple-syrup-urine disease metabolites
27. Metabolism and neurotransmission
28. Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype
29. Deficit in a Krebs cycle mitochondrial enzyme in brains from patients with Parkinson's disease
30. Oxidative stress and a key metabolic enzyme in Alzheimer brains, cultured cells, and an animal model of chronic oxidative deficits
31. Brain dysfunction in mild to moderate hypoxia
32. Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease
33. Alpha-ketoglutarate dehydrogenase in Alzheimer brains bearing the APP670/671 mutation
34. Interaction between catalytic and regulatory sites of the pyruvate dehydrogenase from Escherichia coli studied by the ESR technique
35. Reactive oxygen species and the central nervous system
36. Inhibitors of mitochondrial respiration, iron(II), and hydroxyl radical evoke release and extracellular hydrolysis of glutathione in rat striatum and substantia nigra: Potential implications to Parkinson's disease
37. Thiamine responsive anaemia: A study of two further cases
38. Alterations of thiamine phosphorylation and of thiamine-dependent enzymes in Alzheimer's disease
39. The antioxidant and prooxidant activity of some B vitamins and vitamin- like compounds
40. Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I/glycogen synthase kinase 3beta in brain
41. Nontoxic amyloid beta peptide 1-42 suppresses acetylcholine synthesis. Possible role in cholinergic dysfunction in Alzheimer's disease
42. Selective inactivation of alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase: Reaction of lipoic acid with 4-hydroxy-2-nonenal
43. Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease
44. Effect of various nucleotides and drugs on microsomal thiamine diphosphatase activity in rat brain
45. Stimulation of thiamine diphosphatase activity by ascorbic acid in rat brain microsomes
46. Cerebrospinal fluid levels of thiamine in patients with Parkinson's disease
47. Secondary inhibition of 2-ketoglutarate dehydrogenase complex by MPTP
48. Alzheimer-type pathology in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS)
49. Induction of epitopes associated with neurofibrillary tangles in clonal mouse neuroblastoma (S20Y) cells
50. Association between the gene encoding the E2 subunit of the alpha-ketoglutarate dehydrogenase complex and Parkinson's disease
51. Thiamine corrects delayed replication and decreases production of lactate and advanced glycation end-products in bovine retinal and human umbilical vein endothelial cells cultured under high glucose conditions
52. Distribution of thiamine, thiamine phosphates, and thiamine metabolizing enzymes in neuronal and glial cell enriched fractions of rat brain
53. Thiamine mono- and pyrophosphatase activities from brain homogenate of Guamanian amyotrophic lateral sclerosis and parkinsonism-dementia patients
54. Increased cerebral free radical production during thiamine deficiency
55. Antioxidant properties of thiamine
56. Glucose enhancement of memory in patients with probable senile dementia of the Alzheimer's type
57. Genetic sensitivity to thiamine deficiency and development of alcoholic organic brain disease
58. Molecular genetics of transketolase in the pathogenesis of the Wernicke- Korsakoff syndrome
59. Brain thiamine, its phosphate esters, and its metabolizing enzymes in Alzheimer's disease
60. Brain alpha-ketoglutarate dehydrogenase complex activity in Alzheimer's disease
61. Cerebellar alpha-ketoglutarate dehydrogenase activity is reduced in spinocerebellar ataxia type 1
62. Inhibition of alpha-ketoglutarate dehydrogenase by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
63. Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease
64. Preliminary findings of high-dose thiamine in dementia of Alzheimer's type
65. An immunohistochemical study on alpha-ketoglutarate dehydrogenase complex in Parkinson's disease
66. Role of mitochondria in the etiology and pathogenesis of Parkinson's disease
67. Alzheimer's disease and DLST genotype
68. Specific phosphorylation of Torpedo 43K rapsyn by endogenous kinase(s) with thiamine triphosphate as the phosphate donor
69. A trial of thiamine in Alzheimer's disease
70. Thiamine deficiency results in metabolic acidosis and energy failure in cerebellar granule cells: An in vitro model for the study of cell death mechanisms in Wernicke's encephalopathy
71. Inhibition of select mitochondrial enzymes in PC12 cells exposed to S-(1,1,2,2-tetrafluoroethyl)-L-cysteine
72. Metabolic impairment induces oxidative stress, compromises inflammatory responses, and inactivates a key mitochondrial enzyme in microglia
73. Metabolic impairment elicits brain cell type-selective changes in oxidative stress and cell death in culture
74. Mitochondrial impairment in cerebellum from patients with progressive supranuclear palsy
75. Coenzyme A-acetylating enzymes in Alzheimer's disease: Possible cholinergic 'compartment' of pyruvate dehydrogenase
76. Subacute necrotizing encephalomyelopathy (Leigh's disease): A consideration of clinical features and etiology
77. Cerebrospinal fluid, plasma and erythrocyte thaimine levels in ataxias of degenerative origin
78. Decreased activities of thiamine diphosphatase in frontal and temporal cortex in Alzheimer's disease
79. The aetiology of the sudden infant death syndrome: Current ideas on breathing and sleep and possible links to deranged thiamine neurochemistry
80. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E
81. Thiamine. Twenty years of progress
82. Free radicals and mitochondrial dysfunction in Parkinson's disease
83. Properties and functions of the thiamine diphosphate dependent enzyme transketolase
84. Respiratory failure and stimulation of glycolysis in Chinese hamster ovary cells exposed to normobaric hyperoxia
85. Mitochondrial respiratory enzyme function and superoxide dismutase activity following brain glutathione depletion in the rat
86. Effect of thiamine hydrochloride on lead induced lipid peroxidation in rat liver and kidney
87. Oxidative metabolites of 5-S-cysteinyldopamine inhibit the alpha-ketoglutarate dehydrogenase complex: Possible relevance to the pathogenesis of Parkinson's disease
88. An immunochemical study of the pyruvate dehydrogenase deficit in Alzheimer's disease brain
89. Studies of transketolase abnormality in Alzheimer's disease
90. Abnormality of the alpha-ketoglutarate dehydrogenase complex in fibroblasts from familial Alzheimer's disease
91. Modulation by DLST of the genetic risk of Alzheimer's disease in a very elderly population
92. A DLST genotype associated with reduced risk for Alzheimer's disease
93. Early detection of Alzheimer's disease by combining apolipoprotein E and neuroimaging
94. Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain
95. Affected enzyme activities in Alzheimer's disease are sensitive to antemortem hypoxia
96. The role of alpha-tocopherol and thiamine in the correction of lipid peroxidation in compensatory myocardial hypertrophy
97. The Wernicke-Korsakoff syndrome. A clinical and pathological study of 245 patients, 82 with post-mortem examinations
98. Oxidative metabolites of 5-S-cysteinylnorepinephrine are irreversible inhibitors of mitochondrial complex I and the alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase complexes: Possible implications for neurodegenerative brain disorders